Pruskowski Jennifer, Arnold Robert M
J Palliat Med. 2015 May;18(5):461-2. doi: 10.1089/jpm.2015.1027.
Tramadol has an important position as a Step II agent on the WHO pain ladder, where it is effective for a variety of syndromes in patients with mild to moderate pain intensity. Its recommended dosing adjustments, potential ceiling effect, cost, pertinent drug interactions, and risk for significant adverse drug reactions may limit its chronic use in patients with significant pain.
曲马多作为世界卫生组织疼痛阶梯中的二级药物具有重要地位,对轻至中度疼痛强度患者的多种综合征有效。其推荐的剂量调整、潜在的天花板效应、成本、相关药物相互作用以及发生重大药物不良反应的风险可能会限制其在重度疼痛患者中的长期使用。